Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro® (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)

NCT02227355 is registered in ClinicalTrials.gov with UCB Biopharma S.P.R.L. as lead sponsor.

NCT NCT02227355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02227355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro® (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)
Lead sponsor
UCB Biopharma S.P.R.L.
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
June 30, 2016
Enrollment
195 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

idiopathic parkinson's disease